When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Squamous-cell carcinoma of the lung - Wikipedia

   en.wikipedia.org/wiki/Squamous-cell_carcinoma_of...

   Lung squamous-cell carcinoma is the second most common histologic type of lung cancer after adenocarcinoma, reaching 22.6% of all lung cancer cases as of 2012. [11] The relative incidence of the former has been steadily decreasing in favor of the latter due to the decreasing smoking rates in the last few years. [9]

3. Squamous-cell carcinoma - Wikipedia

   en.wikipedia.org/wiki/Squamous-cell_carcinoma

   Squamous-cell carcinoma (SCC), also known as epidermoid carcinoma, comprises a number of different types of cancer that begin in squamous cells. [1] These cells form on the surface of the skin, on the lining of hollow organs in the body, and on the lining of the respiratory and digestive tracts .

4. Lung cancer - Wikipedia

   en.wikipedia.org/wiki/Lung_cancer

   Lung cancer is the most diagnosed and deadliest cancer worldwide, with 2.2 million cases in 2020 resulting in 1.8 million deaths. [3] Lung cancer is rare in those younger than 40; the average age at diagnosis is 70 years, and the average age at death 72. [2] Incidence and outcomes vary widely across the world, depending on patterns of tobacco use.

5. Treatment of lung cancer - Wikipedia

   en.wikipedia.org/wiki/Treatment_of_lung_cancer

   In 2016, the FDA approved atezolizumab for the treatment of people with metastatic non-small cell lung cancer (NSCLC) whose disease progressed during or following platinum-containing chemotherapy and pembrolizumab for the treatment of people with metastatic non-small cell lung cancer (NSCLC) whose tumors express programmed death-ligand 1 as ...

6. Non-small-cell lung cancer - Wikipedia

   en.wikipedia.org/wiki/Non-small-cell_lung_cancer

   Non-small-cell lung cancer (NSCLC), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers. [1] [2] [3] As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma.

7. Where Will Summit Therapeutics Be in 5 Years? - AOL

   www.aol.com/where-summit-therapeutics-5-years...

   The company is going after an important target: non-small cell lung cancer (NSCLC). In a late-stage study conducted in China, ... (FDA) for the treatment of metastatic non-squamous NSCLC. The fast ...